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ABSTRACT
Introduction A strike is a collective, temporary and 
calculated action, which involves a temporary stoppage 
of work. For healthcare professionals strike action poses 
a unique dilemma. Perhaps most fundamentally, as strike 
action is designed to be disruptive it has the potential to 
impact the delivery of care and place patient well- being 
in jeopardy. The objective of this study is therefore to 
evaluate the impact of healthcare strike action on patient 
mortality outcomes globally using meta- analysis in order 
to provide a comprehensive evidence base that can advise 
healthcare professionals, governments and regulatory 
bodies on the impact that strike action has on patients.
Methods and analysis A comprehensive literature search 
of major electronic databases (EMBASE, MEDLINE, CINAHL, 
BIOETHICSLINE, EconLit, WEB OF SCIENCE, OPEN GREY 
and SIGMA REPOSITORY) will be undertaken to identify 
observational studies of strike action among healthcare 
professionals where in- hospital/clinic and population/
community mortality is examined, prestrike, during and 
poststrike. Meta- analysis will be performed to estimate 
in- hospital/clinic and population/community mortality 
during periods of strike action. The quality of evidence will 
be assessed using the National Institute of Health quality 
assessment tool for observational cohort and cross- 
sectional studies. Risk of bias will be assessed using the 
Cochrane Risk Of Bias In Non- Randomized Studies - of 
Interventions tool.
Ethics and dissemination This study does not require 
ethical approval. Findings will be submitted to an 
appropriate peer- reviewed journal.
Trial registration number CRD42021238879.
BACKGROUND
Strike action in healthcare is a remarkably 
common global phenomenon. A strike 
(or strike action or labour strike) has been 
defined as a ‘temporary stoppage of work 
by a group of employees in order to express 
a grievance or enforce a demand’.1 That is, 
a strike is collective, temporary and calcu-
lated, and is largely distinct from other forms 
of workplace protest and resistance. For 
healthcare professionals, strike action poses 
a unique dilemma. Perhaps most funda-
mentally, as strike action is designed to be 
disruptive it has the potential to impact the 
delivery of care and place patient well- being 
in jeopardy. Beyond this concern, the char-
acteristics of strikes and the patients and 
healthcare systems they impact vary substan-
tially. Healthcare strikes have been docu-
mented on almost every continent, they vary 
in length, from hours to hundreds of days,2 
their demands vary3 and their impact can be 
vastly different.4 The healthcare systems they 
impact also vary substantially, from Kenya, to 
New Zealand to the USA.5 Even until recently, 
strikes have continued to occur throughout 
the COVID- 19 pandemic.6
Over the last four decades the justifiability 
of strike action has been debated in the 
literature in hundreds of articles, letters, 
commentaries and debates. Positions on this 
are often quite polarised, with a number of 
authors arguing that strike action in health-
care cannot be justified in any circumstance. 
Counihan,7 for example, argues that strike 
action was akin to ‘trying to cure a disease 
Strengths and limitations of this study
 ► This study will outline a systematic review and 
meta- analysis to assess the effect strike action has 
on patient and population mortality outcomes.
 ► Mortality is only one measure of patient well- being/
outcomes—there are other qualitative outcomes 
which are not included in this meta- analysis.
 ► It will not be able to fully account for the upstream 
(or knock- on) effects of strike action. This could be 
in hospitals where staff did not go on strike or those 
who did not seek treatment (or sought treatment 
elsewhere) during the strike.
 ► This study will not examine the impact of strike 
action on healthcare delivery (eg, rates of appoint-
ments, waiting times, cancellations).
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by administering poison’. On the other hand, many 
have argued that strike action is not only permissible 
but a duty. Brecher,8 for example, argues that healthcare 
professionals are not under any special moral obliga-
tion that would prevent them from striking, noting that 
‘[u]nless we were all either to agree that human life is 
in all circumstances a completely overriding value … the 
striker whose omissions bring about someone’s death 
has no prima facie moral case to answer’. Loewy9 builds 
a similar case, arguing that healthcare professionals are 
just as essential as those who work in garbage or waste 
disposal, and that ‘[u]ncollected garbage or unprocessed 
sewage are every bit as dangerous and have far more side- 
reaching health effects than do untreated pneumonia 
or appendicitis or coronary bypass surgeries that are 
not performed’. Decades later, these discussions remain 
unsettled and while a number of further ethical consider-
ations can be found throughout the literature, the impact 
of strike action on patient outcomes, rightly, weighs most 
heavily.10 This largely unsettled dilemma has not only 
created fertile ground for ongoing ethical discussion, 
but has left a substantial grey area for healthcare profes-
sionals and regulatory bodies who may be considering or 
facing strike action. For example, during the 2016 UK 
junior doctors strikes, the General Medical Council (the 
UK’s regulatory body for doctors) issued a stark warning, 
urging for strike action to be called off, stating that, ‘we 
believe that, despite everyone’s best efforts, patients will 
suffer’.11
The impact of strike action is measurable and over the 
last several decades’ evidence in relation to such action has 
expanded. In addition to a broad literature debating the 
justifiability of strike action, research exists on the impact 
that strikes have on healthcare delivery, for example, 
patient presentations and admissions and the attitudes 
of patients and healthcare professionals toward such 
action. Given the pressing concerns about patient well- 
being during strike action, an outcome that has received 
particular attention is patient mortality, with a number 
of studies measuring patient mortality in- hospital/clinics 
and in populations/communities during strike action. To 
a lesser extent, a number of other patient outcomes have 
been examined in light of strike action, from immunisa-
tion rates12 to chlamydia rates13 for example.
There is a pressing need for clarity in relation to the 
above literature on patient outcomes. That is, a better 
understanding of how such action impacts patient 
mortality (and other outcomes) will have implications 
for critical normative, practical and regulatory questions 
related to strike action. Whether such action is justified, 
how patient well- being can be protected during a strike 
and whether healthcare professionals should face sanc-
tion for participating, are among a number of important 
questions to which this review will contribute.
The primary objective of this study is therefore to eval-
uate the impact of healthcare strike action on patient 
mortality outcomes globally (specifically in- hospital/clinic 
and population/community mortality captured prestrike, 
during and in poststrike periods) using meta- analysis in 
order to provide a comprehensive evidence base that 
contributes to ethical, practical and regulatory decision 
making in relation to strike action. The in- hospital/clinic 
distinction has been made to ensure global inclusivity, 
for example, some countries do not have hospitals but 
instead provide healthcare from a clinical setting of sorts 
such as a rural clinic that serves as a hospital. The popula-
tion/community distinction has been made in relation to 
the types of data individual studies may provide.
REVIEW QUESTION
What is the impact of healthcare strike action on patient 
mortality outcomes globally?
METHODS
This protocol conforms to Preferred Reporting Items 
for Systematic Review and Meta- Analysis Protocols 
guidelines14 for the reporting of systematic review and 
meta- analysis protocols (see online supplemental file 
1). Eligibility criteria were developed using the PECOS 
(Population, Exposure, Comparator, Outcomes, Study 
design) framework,15 which is summarised in table 1 and 
described in detail in the later sections.
Table 1 Summary of the PECOS eligibility criteria (detailed descriptions in manuscript text)
Inclusion criteria Exclusion criteria
Population Patients presenting or admitted to hospital or a 
healthcare service (in- hospital/clinic mortality) and the 
general/local population (population mortality)
Outpatient services; alternative health- related services
Exposure Period of strike by healthcare professionals Strike of non- professional healthcare staff or healthcare 
services where healthcare professionals have not gone 
on strike (eg, upstream effects of strike)




Study design Observational studies comparing patient mortality 
during and prestrike/poststrike
Qualitative studies and other studies that are not 
observational such as experimental studies
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Patient/population
We will include studies of patients receiving care from 
hospitals/clinics before, during and after a period of 
strike (to identify how patients in hospitals/clinics are 
impacted by strike action). We will include all patients 
impacted by strike action in- hospital, however, where 
data exists about patient acuity this will be reported. We 
will also include studies that examine mortality in the 
general population/community under study before, 
during and after a period of strike action (to identify 
the broader effects of the strike, for example, people 
who died at home because they didn’t seek treatment/
sought treatment elsewhere). For our analysis of in- hos-
pital mortality we have excluded outpatient and alterna-
tive health services as in many cases, these services would 
not be comparable to hospital environments and would 
have further complicated the results, for example, outpa-
tient and alternative health services are likely to witness 
far fewer deaths and far less acute patients even outside 
periods of strike action.
Interventions
Our intervention event will be strike action by healthcare 
professionals. Non- professional healthcare strikes will 
be excluded (eg, porters, drivers, cleaners, administra-
tive staff). When there is a mix of both professional and 
non- professional healthcare staff striking we will include 
the study. For these purposes, we will define healthcare 
professionals as defined in the UK as ‘a person associated 
with either a specialty or a discipline and who is qualified 
and allowed by regulatory bodies to provide a healthcare 
service to a patient’.16 Healthcare professionals will there-
fore include doctors, nurses, physiotherapists, dieticians 
and paramedics, among others.
Comparison




 ► In- hospital/clinic mortality.
 – In- hospital/clinic mortality during a strike period 
will be examined against a comparable time peri-
od before and/or after the strike action. Mortality 
rates for each period will be compared.
 – Where possible, prestrike and poststrike control 
periods will be examined to analyse if the strike it-
self has any effect on patient mortality.
 ► Population mortality.
 – Population mortality during a strike period will be 
examined against a comparable time period before 
and/or after the strike action. Mortality rates for 
each period will be compared.
Note that consideration will be given to the duration of 
the no strike comparison compared with the strike and 
whether it is prestrike and poststrike.
Study design
Due to the nature of strikes, this is the best available 
evidence that can be included in this type of synthesis. 
Observational studies comparing patient mortality 
during and prestrike/poststrike. Observational studies 
can include cohort, longitudinal and cross- sectional 
designs.
Measures of effect size
For each study, we will compute the relative risk (RR) of 
mortality: during versus prestrike/poststrike.
Information sources
The following electronic databases and time periods 
will be searched: EMBASE (1980–2021), MEDLINE 
(1946–2021), CINAHL (1982–2021), BIOETHICSLINE 
(1972–1999), (This time period has not been limited by 
the researchers, papers were only indexed in BIOETH-
ICSLINE from 1972 to 1999.) EconLit (1969–2021), 
WEB OF SCIENCE (1960–2021). In addition, grey liter-
ature will be searched through OPEN GREY, and SIGMA 
REPOSITORY.
Where complete data for a relevant outcome are not 
available from a report of an eligible study we will contact 
authors to request data. In addition, we will conduct a 
manual search of reference lists of eligible studies.
Search strategy
Search terms have been developed to capture the core 
concepts, related to the form of intervention we are 
interested in (eg, strike action, industrial action) and the 
populations in question (eg, doctors, nurses, healthcare 
professionals). The final search terms will be: strike OR 
“industrial action” OR “industrial dispute” OR “collec-
tive action” AND doctor OR physician OR clinician OR 
“medical practitioner” OR nurs* OR “health profes-
sion*” OR healthcare OR “health care” OR “pharmac*” 
OR “dentist” OR “midwi*” OR dieti* OR “occupational 
therap*” OR “paramed*” OR “physiotherap*” OR 
“radiograph*” OR “psycholog*” OR “health worker” OR 
“hospital”. There will be no publication dates or language 
restrictions. If there is a period greater than 3 months 
from the initial search to journal submission then another 
search for that time period will be conducted to bring the 
search up to date. For an expanded search strategy see 
online supplemental file 2.
Study selection
Titles and abstracts of the initial searches will be inde-
pendently screened by RE and one other member of the 
review team, who will exclude studies not meeting the 
eligibility criteria. RE and one other reviewer will then 
independently screen the full- text of the remaining 
articles, retaining only eligible studies for inclusion. 
Disagreements at any stage will be resolved through 
discussion or with a third member of the review team if 
necessary.
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CODING AND STATISTICAL ANALYSIS PLAN
Data extraction
One reviewer (RE) will perform data extraction, with 
extracted data checked for accuracy by SMW. Informa-
tion extracted will include:
 ► Study characteristics (such as study design, geograph-
ical location and year in which the strike took place).
 ► Overview of the strike characteristics, professionals 
involved, length of strike and length of control 
period(s).
 ► Mortality outcome results and whether there was 
adjustment for potential confounders in the analyses.
 ► Source of data (eg, administrative database, popula-
tion mortality statistics).
 ► Any other contextual details about the strike which 
may be relevant.
Missing data
Where there is missing data; study authors will be 
contacted for unreported data and additional details.
Study characteristics
We will generate a descriptive table summarising the key 
characteristics of each eligible study including the type of 
strike, the professionals involved and the patient popula-
tions and in- hospital services affected.
Meta-analysis
Meta- analysis will be used to systematically synthe-
sise the findings of the single, independent studies 
retrieved from the search and included for analysis. 
The RR will be calculated for each study. We will pool 
RRs using a random- effects model and test for hetero-
geneity (see later). A random- effects method for dichot-
omous outcomes can combine ORs, risks ratios or risk 
differences and can be conducted in RevMan where 
log transformations can also be conducted. If a meta- 
analysis is not possible due to too few results or for any 
other reasons, the authors will assess the suitability of 
conducting an alternate synthesis.
Analysis of sub-groups
If possible, we may do subanalysis of the length of strike, 
professionals involved, services affected and geographical 
location. We will conduct the subanalysis if there are a 
minimum of two studies that can be meaningfully pooled 
and their results are sufficiently similar. If studies are 
not similar, we will conduct subanalysis if there are four 
studies.17
Heterogeneity
We will test for variation in effect sizes within a set of 
studies for the same comparison by computing the I2 
statistic, which estimates the proportion of variance in 
effect sizes due to true heterogeneity. We will also report 
τ as a measure of heterogeneity for each comparison, 
which gives the SD of the effect size estimate.
Sensitivity analysis
We will assess the robustness of the findings to various 
types of strikes (length, location, etc) by performing 
sensitivity analyses including removing studies with a 
high risk of bias, that is, where overall bias is assessed as 
being critical using the Risk Of Bias In Non- Randomized 
Studies - of Interventions (ROBINS- I).
Evidence grading
The quality of the study evidence for the primary 
outcome of mortality will be evaluated using the National 
Institute of Health quality assessment tool18 for observa-
tional cohort and cross- sectional studies and presented 
in a Summary of Findings table. Within- study bias will 
be assessed with the Cochrane ROBINS- I tool,19 which 
rates potential for study bias arising preintervention 
(confounders, participant selection), during the inter-
vention (classification of intervention) and postinterven-
tion (deviations, missing data, outcome measurement, 
result selection). Two authors will conduct the assessment 
and a third will look at a random sample assessments.
Patient and public involvement
This study is a synthesis of secondary data and will not 
require patient or public involvement.
ETHICS AND DISSEMINATION
This review does not require ethical approval, as it will use 
secondary data that is already publicly available. We will 
disseminate our findings by publishing results in a peer- 
reviewed journal.
Twitter Sharon Marie Weldon @sharonmweldon
Contributors RE conceived the study and developed the study design and 
protocol. SMW and TT provided substantial contribution to the study design, 
statistical analysis plan and the writing of the protocol. EK, PM and SD contributed 
to the design and writing of the protocol. All authors evaluated the study protocol 
critically for important intellectual content and contributed to its revisions. All the 
authors gave the final approval to publish the current protocol.
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SUPPLEMENTARY FILE 1 – PRISMA-P  
 
PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) 2015 checklist: recommended items to address in a 
systematic review protocol*  
Section and topic Item 
No 
Checklist item  
ADMINISTRATIVE INFORMATION  
Title:    
 Identification 1a Identify the report as a protocol of a systematic review p.1 
 Update 1b If the protocol is for an update of a previous systematic review, identify as such n/a 
Registration 2 If registered, provide the name of the registry (such as PROSPERO) and registration number p.2 
Authors:    
 Contact 3a Provide name, institutional affiliation, e-mail address of all protocol authors; provide physical mailing address of corresponding author p.1 
 Contributions 3b Describe contributions of protocol authors and identify the guarantor of the review p.1 
Amendments 4 If the protocol represents an amendment of a previously completed or published protocol, identify as such and list changes; otherwise, 
state plan for documenting important protocol amendments 
n/a 
Support:    
 Sources 5a Indicate sources of financial or other support for the review p.12 
 Sponsor 5b Provide name for the review funder and/or sponsor p.11 
 Role of sponsor 
or funder 
5c Describe roles of funder(s), sponsor(s), and/or institution(s), if any, in developing the protocol p.11 
INTRODUCTION  
Rationale 6 Describe the rationale for the review in the context of what is already known p.4-5 




BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) BMJ Open
 doi: 10.1136/bmjopen-2021-050826:e050826. 11 2021;BMJ Open, et al. Essex R
Eligibility criteria 8 Specify the study characteristics (such as PICO, study design, setting, time frame) and report characteristics (such as years considered, 
language, publication status) to be used as criteria for eligibility for the review 
p.6-8 
Information sources 9 Describe all intended information sources (such as electronic databases, contact with study authors, trial registers or other grey literature 
sources) with planned dates of coverage 
p.8 
Search strategy 10 Present draft of search strategy to be used for at least one electronic database, including planned limits, such that it could be repeated p.9 
Study records:    
 Data 
management 
11a Describe the mechanism(s) that will be used to manage records and data throughout the review p.9-11 
 Selection 
process 
11b State the process that will be used for selecting studies (such as two independent reviewers) through each phase of the review (that is, 
screening, eligibility and inclusion in meta-analysis) 
p.9 
 Data collection 
process 
11c Describe planned method of extracting data from reports (such as piloting forms, done independently, in duplicate), any processes for 
obtaining and confirming data from investigators 
p.9-10 





13 List and define all outcomes for which data will be sought, including prioritization of main and additional outcomes, with rationale p.7-8 
Risk of bias in 
individual studies 
14 Describe anticipated methods for assessing risk of bias of individual studies, including whether this will be done at the outcome or study 
level, or both; state how this information will be used in data synthesis 
p.11 
Data synthesis 15a Describe criteria under which study data will be quantitatively synthesised p.10 
15b If data are appropriate for quantitative synthesis, describe planned summary measures, methods of handling data and methods of 
combining data from studies, including any planned exploration of consistency (such as I2, Kendall’s τ) 
p.10 
15c Describe any proposed additional analyses (such as sensitivity or subgroup analyses, meta-regression) p.10-11 
15d If quantitative synthesis is not appropriate, describe the type of summary planned p.10-11 
Meta-bias(es) 16 Specify any planned assessment of meta-bias(es) (such as publication bias across studies, selective reporting within studies) p.10-11 
Confidence in 
cumulative evidence 
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SUPPLEMENTARY FILE 2 – EXPANDED SEARCH STRATEGY 
 
EMBASE  
((strike or "industrial action" or "industrial dispute" or "collective action") and (doctor or physician or 
clinician or "medical practitioner" or nurs* or "health profession*" or healthcare or "health care" or 
pharmac* or dentist or midwi* or dieti* or "occupational therap*" or paramed* or physiotherap* or 
radiograph* or psycholog* or "health worker" or hospital)).ab 
 
MEDLINE 
((strike or "industrial action" or "industrial dispute" or "collective action") and (doctor or 
physician or clinician or "medical practitioner" or nurs* or "health profession*" or healthcare 
or "health care" or pharmac* or dentist or midwi* or dieti* or "occupational therap*" or 
paramed* or physiotherap* or radiograph* or psycholog* or "health worker" or hospital)).ab. 
 
CINAHL  
AB ( strike or "industrial action" or "industrial dispute" or "collective action" ) AND AB ( 
doctor or physician or clinician or "medical practitioner" or nurs* or "health profession*" or 
healthcare or "health care" or pharmac* or dentist or midwi* or dieti* or "occupational therap*" 
or paramed* or physiotherap* or radiograph* or psycholog* or "health worker" or hospital )  
 
EconLit 
AB ( strike or "industrial action" or "industrial dispute" or "collective action" ) AND AB ( 
doctor or physician or clinician or "medical practitioner" or nurs* or "health profession*" or 
healthcare or "health care" or pharmac* or dentist or midwi* or dieti* or "occupational therap*" 
or paramed* or physiotherap* or radiograph* or psycholog* or "health worker" or hospital ) 
 
WEB OF SCIENCE 
TITLE: (strike or "industrial action" or "industrial dispute" or "collective action") AND TITLE: 
(doctor or physician or clinician or "medical practitioner" or nurs* or "health profession*" or 
healthcare or "health care" or pharmac* or dentist or midwi* or dieti* or "occupational therap*" 
or paramed* or physiotherap* or radiograph* or psycholog* or "health worker" or hospital) 
 
BIOETHICSLINE 
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(strike OR "industrial action" OR "industrial dispute" OR "collective action") AND (doctor 
OR physician OR clinician OR "medical practitioner" OR nurs* OR "health profession*" OR 
healthcare OR "health care" OR pharmac* OR dentist OR midwi* OR dieti* OR "occupational 




(strike OR "industrial action" OR "industrial dispute" OR "collective action") AND (doctor 
OR physician OR clinician OR "medical practitioner" OR nurs* OR "health profession*" OR 
healthcare OR "health care" OR pharmac* OR dentist OR midwi* OR dieti* OR "occupational 




(strike OR "industrial action" OR "industrial dispute" OR "collective action") AND (doctor 
OR physician OR clinician OR "medical practitioner" OR nurs* OR "health profession*" OR 
healthcare OR "health care" OR pharmac* OR dentist OR midwi* OR dieti* OR "occupational 
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